Matthew Kobylinski 1 2, Nina Krupa 1 2, Hollis Tam 1, Linda Nguyen 1, Julia R Jahansooz 1 2, Kylie Herndon 1 3, Kaelyn Pacpaco 1 4, Masako Matsunaga 2, Samuel Toh Kim 1, Qi Zhi 1, Michael Sonson 1,…
Blood Biomarkers, Latest Treatments, and Brain Health Insights Alzheimer’s disease is one of the most talked-about—and misunderstood—neurological conditions today. With constant news headlines, social media discussions, and emerging research, patients and families are often left confused about what is true,…
Eli Snyder1,2, Ryan Nakamura1,2, Miriya Ogawa1,3, Kaylin Bersamin1,4, Kyle Ishikawa2, Hyeong Jun Ahn 3, Enrique Carrazana, MD1, Kore Liow, MD1 Janette Abramowitz, MD1 1Center for Psychiatric Neuroscience, BRAIN Hawaii Pacific Neuroscience, Honolulu, HI, USA.2John A. Burns School of Medicine, University…
A two-year international study highlights the potential benefits of vagus nerve stimulation (VNS) therapy for individuals living with Lennox–Gastaut syndrome (LGS), a rare and severe form of childhood epilepsy. The findings demonstrate that long-term VNS therapy can reduce seizure frequency,…
A peer-reviewed study published in Epilepsia (October 2025) evaluated the pharmacokinetics, safety, and tolerability of single-dose Staccato® alprazolam in adolescents with epilepsy. The findings support appropriate dose selection for adolescents aged 12–17 years, contributing important evidence toward the clinical development…
Hawaii Memory & Alzheimer’s Research has joined leading academic institutions—including UCSF, UC San Diego, and the Cleveland Clinic—in a multicenter clinical trial investigating VHB937, a novel TREM2-stabilizing monoclonal antibody engineered to cross the blood–brain barrier and reduce neuroinflammation in Alzheimer’s…
The Hawaii Parkinson’s & Movement Center and Hawaii Parkinson’s Research Unit have been awarded Hawaiʻi’s first clinical research study focused on Lewy Body Dementia (LBD). This landmark study investigates ACP-204 (remlifanserin), an investigational medication developed to treat hallucinations and delusions…
Researchers at the Hawaii Parkinson’s Disease Center and Hawaii Parkinson’s Research Unit are participating in groundbreaking research evaluating prasinezumab, an investigational monoclonal antibody that may become the first disease-modifying treatment to slow the progression of Parkinson’s disease. This research is…
Accurate detection of mild cognitive impairment (MCI) and Alzheimer’s disease (AD) is critical as therapeutic strategies increasingly emphasize early intervention. While the Mini-Mental State Examination (MMSE) remains a widely used cognitive screening tool, its sensitivity to subtle neurophysiological changes is…
Early and accurate differentiation between Alzheimer’s disease (AD) and mild cognitive impairment (MCI) is increasingly critical as new disease-modifying therapies emphasize intervention at the earliest possible stages. However, MCI often represents a heterogeneous and nonspecific prodromal phase, complicating clinical diagnosis…
RECENT BLOGS
-
Dr. Natalia Gonzalez Caldito Named Chief of Staff at Hawaiʻi Pacific Neuroscience
-
Hawaii Pacific Neuroscience Physicians Named 2026 Castle Connolly Top Doctors
-
Dr. Kore Kai Liow Named 2026 Hawaii Physician of the Year | HPN
-
University of Hawaii Professor & Researcher Publishes Buntanetap Study in Nature — A Novel Oral Therapy Targeting APP and Tau in Alzheimer’s Disease
-
A Triple Burden In Native Hawaiian And Pacific Islander Patients With Epilepsy: The Cardiometabolic Risks Of Obesity, Diabetes, Smoking, And Their Association With Seizure Control
-
2026 Hawaii Comprehensive Epilepsy Ctr & Epilepsy Research Unit in Hawaii Awarded Study to Investigate Novel anti-Galectin-3 monoclonal Antibody for the Drug-Resistant Epilepsy (DRE)
-
Hawaii Selected to Investigate Povetacicept for Myasthenia Gravis
-
Assessing the Understanding of Neurological Conditions in Young Adults and Leveraging Media Outlets and Social Media Platforms for Neurology Awareness
HPN Office Hours
Monday :
8AM - 5PM
Tuesday :
8AM - 5PM
Wednesday :
8AM - 5PM
Thursday :
8AM - 5PM
Friday :
8AM - 5PM
Saturday :
CLOSED
SUNDAY :
CLOSED